Nagashree Seetharamu, MD
Internal Medicine · New Hyde Park, NYNPI 1124198833
Payments from drug & device makers
Across 287 payments — averaging $8586.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.1M
- E.r. Squibb & Sons, L.L.C.$459K
- Genentech, Inc.$309K
- AVEO Pharmaceuticals, Inc.$109K
- Boehringer Ingelheim Pharma GmbH & Co.kg$105K
- AbbVie$76K
- plus $315K from 22 others
Across 8 payments — averaging $693.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$5K
- Regeneron$920
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 42 | $1,090,537 |
| E.r. Squibb & Sons, L.L.C. | 3 | $458,835 |
| Genentech, Inc. | 85 | $309,432 |
| AVEO Pharmaceuticals, Inc. | 9 | $108,925 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 4 | $105,401 |
| AbbVie | 11 | $76,149 |
| Amgen | 23 | $74,567 |
| Boehringer Ingelheim | 8 | $59,746 |
| Beigene, Ltd. | 14 | $53,021 |
| AstraZeneca | 21 | $41,759 |
| Mirati Therapeutics, Inc. | 20 | $36,987 |
| Coherus Oncology, Inc. | 4 | $9,741 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $8,857 |
| Eisai Inc. | 4 | $5,325 |
| EMD Serono, Inc. | 5 | $4,238 |
| Janssen Scientific Affairs, LLC | 3 | $3,908 |
| Genentech USA, Inc. | 5 | $3,833 |
| Pfizer | 2 | $2,600 |
| Nuvation Bio Inc. | 1 | $2,520 |
| Regeneron Healthcare Solutions, Inc. | 1 | $2,293 |
| Blueprint Medicines Corporation | 1 | $2,016 |
| Boehringer Ingelheim International GmbH | 1 | $1,443 |
| Novocure Inc. | 2 | $699 |
| Jazz Pharmaceuticals Inc. | 5 | $572 |
| Array Biopharma Inc | 1 | $500 |
| Daiichi Sankyo Inc. | 2 | $198 |
| Galvanize Therapeutics, Inc | 1 | $74 |
| Lilly USA, LLC | 1 | $26 |
How this compares
$2,464,200 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in New Hyde Park
- Janice WangNew Hyde Park$2.1M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.